In December, the U.S. Food and Drug Administration (FDA) issued warning letters to online retailers for reportedly selling unauthorized e-cigarette products. Consistent with the Center for Tobacco Products’ (CTP) recent focus, the letters target unauthorized products, which FDA states are particularly appealing to youth — including Lost Mary, Funky Republic/Funky Lands, and Elf Bar/EB Design. These warning letters follow FDA’s recent issuance of civil money penalty complaints against 25 brick-and-mortar retailers for failing to comply with prior warning letters. Those civil money penalty complaints, which we previously discussed here, continued the agency’s approach of seeking the maximum penalty approved by law.

FDA may also be signaling a shift to a more wide-ranging enforcement strategy. In 2020, the agency stated that it would prioritize enforcement against unauthorized e-cigarettes for which it had not received a timely premarket tobacco application (PMTA). Similarly in 2022, when Congress extended FDA’s tobacco product authorities to cover e-cigarettes using nontobacco-derived nicotine, it appeared the agency had taken an unstated approach of not bringing enforcement action against synthetic nicotine products with timely applications.

In an FDA press release accompanying the issuance of the December warning letters, however, CTP Director Dr. Brian King clarified that FDA’s enforcement may not be so constrained. In pertinent part, he warns, “We can issue, and have issued, warning letters for products for which an application has been submitted and is pending review. For unauthorized tobacco products, the pendency of an application does not create any sort of safe harbor to sell that product.” If any of the products at issue have timely pending PMTAs, then this action may be considered a shift in FDA’s approach, demonstrating that FDA may prioritize enforcement against e-cigarettes that it believes appeal to youth regardless of a timely application.

Concerns of youth appeal of certain e-cigarettes continue to drive FDA’s enforcement priorities. In the same press release, FDA cited a finding by its recent 2023 National Youth Tobacco Survey that “Elf Bar was the most commonly used e-cigarette brand among youth.” FDA further noted that the other illegal e-cigarette varieties targeted in its warning letters were likewise identified in the survey as popular with youth.

The recent warning letters and civil money penalty complaints — coupled with Dr. King’s warning regarding enforcement during application pendency — reflect FDA’s relatively new focus on illicit e-cigarette sales. As of December 2023, FDA has issued more than 400 such warning letters to retailers regarding unauthorized e-cigarettes, and filed more than 65 civil money penalty complaints to retailers and manufacturers regarding such products. We expect this pattern of enforcement against manufacturers, distributors, and retailers of e-cigarettes lacking FDA authorization to continue into 2024.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Bryan Haynes Bryan Haynes

Bryan Haynes serves clients by developing and implementing creative solutions for complex issues. Specializing in tobacco industry regulatory compliance and enforcement matters, Bryan efficiently assists clients in complying with regulatory obligations and managing risk, consistent with clients’ business objectives.

Photo of Agustin Rodriguez Agustin Rodriguez

Agustin is sought after by clients for his strategic counsel on their most challenging competitive and regulatory compliance issues, including tobacco Master Settlement Agreement issues, federal and state enforcement investigations, licensing and excise tax issues, developing compliance programs, and evaluating advertising and marketing…

Agustin is sought after by clients for his strategic counsel on their most challenging competitive and regulatory compliance issues, including tobacco Master Settlement Agreement issues, federal and state enforcement investigations, licensing and excise tax issues, developing compliance programs, and evaluating advertising and marketing practices. A partner in the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group as well as its Tobacco and Cannabis law practices, he represents manufacturers, distributors, retailers, and suppliers in all aspects of their businesses, including regulatory compliance, FDA requirements, administrative disputes involving federal or state governmental entities, mergers and acquisitions, commercial agreements, and taxation matters.

Photo of Michael Jordan Michael Jordan

Michael Jordan is an associate in Troutman Pepper’s Richmond office. Michael draws on a diverse range of experiences in government and private practice to help clients navigate complex regulatory issues. He focuses primarily on heavily regulated industries, such as tobacco and cannabis.

Photo of Zie Alere Zie Alere

Zie is an associate in the firm’s Regulatory Investigations, Strategy + Enforcement Practice Group. He assists in developing effective strategies to help deter or mitigate the risk of enforcement actions and litigation. As a summer associate, Zie drafted compliance guidelines, worked on pro…

Zie is an associate in the firm’s Regulatory Investigations, Strategy + Enforcement Practice Group. He assists in developing effective strategies to help deter or mitigate the risk of enforcement actions and litigation. As a summer associate, Zie drafted compliance guidelines, worked on pro bono matters, and created analytical memoranda.